Dadi Gao

Dadi Gao

Auto-generated profile, based on publicly available information

Dadi Gao

Center for Genomic Medicine, Massachusetts General Hospital

Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
12 October 2015 in Oncogene
Verified
Journal Article
Open access
PDF file
MGM van Geldermalsen
M van Geldermalsen
QWQ Wang
Q Wang
RNR Nagarajah
R Nagarajah
AMA D Marshall
A D Marshall
ATA Thoeng
A Thoeng
JHJ Holst
J Holst
Alanine, serine, cysteine-preferring transporter 2 (ASCT2; SLC1A5) mediates uptake of glutamine, a conditionally essential amino acid in rapidly proliferating tumour cells. Uptake of glutamine and subsequent glutaminolysis is critical for activation of the mTORC1 nutrient-sensing pathway, which regulates cell growth and protein translation in cancer cells. This is of particular interest in breast cancer, as glutamine dependence is increased in high-risk breast cancer subtypes. Pharmacological inhibitors of ASCT2-mediated transport significantly reduced glutamine uptake in human breast cancer cell lines, leading to the suppression of mTORC1 signalling, cell growth and cell cycle progression. Notably, these effects were subtype-dependent, with ASCT2 transport critical only for triple-negative (TN) basal-like breast cancer cell growth compared with minimal effects in luminal breast cancer cells. Both stable and inducible shRNA-mediated ASCT2 knockdown confirmed that inhibiting ASCT2 function was sufficient to prevent cellular proliferation and induce rapid cell death in TN basal-like breast cancer cells, but not in luminal cells. Using a bioluminescent orthotopic xenograft mouse model, ASCT2 expression was then shown to be necessary for both successful engraftment and growth of HCC1806 TN breast cancer cells in vivo. Lower tumoral expression of ASCT2 conferred a significant survival advantage in xenografted mice. These responses remained intact in primary breast cancers, where gene expression analysis showed high expression of ASCT2 and glutamine metabolism-related genes, including GLUL and GLS, in a cohort of 90 TN breast cancer patients, as well as correlations with the transcriptional regulators, MYC and ATF4. This study provides preclinical evidence for the feasibility of novel therapies exploiting ASCT2 transporter activity in breast cancer, particularly in the high-risk basal-like subgroup of TN breast cancer where there is not only high expression of ASCT2, but also a marked reliance on its activity for sustained cellular proliferation.

1 August 2013 in Cell
Verified
Journal Article
Closed access
Justin WongJustin Wong
Justin Wong
WRWilliam Ritchie
William Ritchie
OEOlivia A. Ebner
Olivia A. Ebner
MSMatthias Selbach
Matthias Selbach
JWJason W. H. Wong
Jason W. H. Wong
JRJohn E.J. Rasko
John E.J. Rasko

19 February 2015 in The Journal of Pathology
Verified
Journal Article
Open access
PDF file
QWQian Wang
Qian Wang
RHRae‐Anne Hardie
Rae‐Anne Hardie
AHAndrew Hoy
Andrew Hoy
MGMichelle van Geldermalsen
Michelle van Geldermalsen
DGDadi Gao
Dadi Gao
JHJeff Holst
Jeff Holst
Glutamine is conditionally essential in cancer cells, being utilized as a carbon and nitrogen source for macromolecule production, as well as for anaplerotic reactions fuelling the tricarboxylic acid (TCA) cycle. In this study, we demonstrated that the glutamine transporter ASCT2 (SLC1A5) is highly expressed in prostate cancer patient samples. Using LNCaP and PC‐3 prostate cancer cell lines, we showed that chemical or shRNA‐mediated inhibition of ASCT2 function in vitro decreases glutamine uptake, cell cycle progression through E2F transcription factors, mTORC1 pathway activation and cell growth. Chemical inhibition also reduces basal oxygen consumption and fatty acid synthesis, showing that downstream metabolic function is reliant on ASCT2‐mediated glutamine uptake. Furthermore, shRNA knockdown of ASCT2 in PC‐3 cell xenografts significantly inhibits tumour growth and metastasis in vivo, associated with the down‐regulation of E2F cell cycle pathway proteins. In conclusion, ASCT2‐mediated glutamine uptake is essential for multiple pathways regulating the cell cycle and cell growth, and is therefore a putative therapeutic target in prostate cancer. © 2015 The Authors. The Journal of Pathology published by John Wiley & Sons Ltd on behalf of Pathological Society of Great Britain and Ireland.

15 March 2017 in Genome Biology
Verified
Journal Article
Open access
PDF file
RMRobert Middleton
Robert Middleton
DGDadi Gao
Dadi Gao
ATAubin Thomas
Aubin Thomas
BSBabita Singh
Babita Singh
AAAmy Au
Amy Au
WRWilliam Ritchie
William Ritchie
Intron retention (IR) occurs when an intron is transcribed into pre-mRNA and remains in the final mRNA. We have developed a program and database called IRFinder to accurately detect IR from mRNA sequencing data. Analysis of 2573 samples showed that IR occurs in all tissues analyzed, affects over 80% of all coding genes and is associated with cell differentiation and the cell cycle. Frequently retained introns are enriched for specific RNA binding protein sites and are often retained in clusters in the same gene. IR is associated with lower protein levels and intron-retaining transcripts that escape nonsense-mediated decay are not actively translated.

1 February 2018 in Cell
Verified
Journal Article
Closed access
TATatsiana Aneichyk
Tatsiana Aneichyk
WHWilliam T. Hendriks
William T. Hendriks
RYRachita Yadav
Rachita Yadav
DSDavid Shin
David Shin
DGDadi Gao
Dadi Gao
MTMichael E. Talkowski
Michael E. Talkowski

8 May 2017 in Nature Communications
Verified
Journal Article
Open access
PDF file
Justin WongJustin Wong
Justin Wong
DGDadi Gao
Dadi Gao
TNTrung V. Nguyen
Trung V. Nguyen
CKChau-To Kwok
Chau-To Kwok
MGMichelle van Geldermalsen
Michelle van Geldermalsen
JRJohn E.J. Rasko
John E.J. Rasko
While intron retention (IR) is considered a widely conserved and distinct mechanism of gene expression control, its regulation is poorly understood. Here we show that DNA methylation directly regulates IR. We also find reduced occupancy of MeCP2 near the splice junctions of retained introns, mirroring the reduced DNA methylation at these sites. Accordingly, MeCP2 depletion in tissues and cells enhances IR. By analysing the MeCP2 interactome using mass spectrometry and RNA co-precipitation, we demonstrate that decreased MeCP2 binding near splice junctions facilitates IR via reduced recruitment of splicing factors, including Tra2b, and increased RNA polymerase II stalling. These results suggest an association between IR and a slower rate of transcription elongation, which reflects inefficient splicing factor recruitment. In summary, our results reinforce the interdependency between alternative splicing involving IR and epigenetic controls of gene expression.